Goethe University is a university located in Frankfurt am Main, Germany. It was founded in 1914 as a citizens' university, which means it was founded and funded by the wealthy and active liberal citizenry of Frankfurt. The original name was Universität Frankfurt am Main.

During the past decade, Johann Wolfgang Goethe University conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 8 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johann Wolfgang Goethe University" #1 sponsor was "Johann Wolfgang Goethe University Hospital" with 12 trials, followed by "Goethe University" with 8 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored, "Celgene" with 4 trials sponsored and "Aimmune Therapeutics, Inc." with 4 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johann Wolfgang Goethe University" #1 collaborator was "Goethe University" with 3 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator, "European Society of Cataract and Refractive Surgeons" with 2 trials as a collaborator, "University of Roma La Sapienza" with 2 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Johann Wolfgang Goethe University" are "Cystic Fibrosis" (6 trials), "Aortic Valve Stenosis" (3 trials), "Cataract" (3 trials), "Crohn Disease" (3 trials) and "Peanut Allergy" (3 trials). Many other conditions were trialed in "Johann Wolfgang Goethe University" in a lesser frequency.

Most popular intervention types in "Johann Wolfgang Goethe University" are "Drug" (24 trials), "Device" (10 trials), "Other" (8 trials), "Procedure" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "ELX/TEZ/IVA" (6 trials), "IVA" (6 trials), "Placebo" (6 trials), "Ozanimod" (3 trials) and "Placebo (matched to ELX/TEZ/IVA)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Johann Wolfgang Goethe University" are 60 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 18 active trials in "Johann Wolfgang Goethe University". 1 are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Johann Wolfgang Goethe University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Johann Wolfgang Goethe University, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".

Johann Wolfgang Goethe University has several departments that took part in Clinical trials: "Department of Sports Medicine, Goethe University Frankfurt/Main" - 7 trials, "Children's Hospital, Goethe-University" - 5 trials, "University of Frankfurt, Medical Dept. II" - 5 trials, "Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University" - 6 trials, "Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University" - 2 trials